Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 1
1999 5
2002 1
2003 1
2007 1
2008 2
2009 1
2010 1
2011 1
2012 1
2013 4
2014 2
2015 4
2016 4
2017 5
2018 5
2019 10
2020 8
2021 7
2022 11
2023 6
2024 8
2025 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

92 results

Results by year

Filters applied: . Clear all
Page 1
Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial.
Nakagawa K, Garon EB, Seto T, Nishio M, Ponce Aix S, Paz-Ares L, Chiu CH, Park K, Novello S, Nadal E, Imamura F, Yoh K, Shih JY, Au KH, Moro-Sibilot D, Enatsu S, Zimmermann A, Frimodt-Moller B, Visseren-Grul C, Reck M; RELAY Study Investigators. Nakagawa K, et al. Lancet Oncol. 2019 Dec;20(12):1655-1669. doi: 10.1016/S1470-2045(19)30634-5. Epub 2019 Oct 4. Lancet Oncol. 2019. PMID: 31591063 Clinical Trial.
EML4-ALK: Update on ALK Inhibitors.
Bearz A, Bertoli E, Stanzione B, De Carlo E, Del Conte A, Bortolot M, Torresan S, Berto E, Da Ros V, Pelin GM, Fassetta K, Rossetto S, Spina M. Bearz A, et al. Among authors: del conte a. Int J Mol Sci. 2025 Jan 1;26(1):308. doi: 10.3390/ijms26010308. Int J Mol Sci. 2025. PMID: 39796163 Free PMC article. Review.
Genetic variants and phenotypic data curated for the CAGI6 intellectual disability panel challenge.
Aspromonte MC, Del Conte A, Polli R, Baldo D, Benedicenti F, Bettella E, Bigoni S, Boni S, Ciaccio C, D'Arrigo S, Donati I, Granocchio E, Mammi I, Milani D, Negrin S, Nosadini M, Soli F, Stanzial F, Turolla L, Piovesan D, Tosatto SCE, Murgia A, Leonardi E. Aspromonte MC, et al. Among authors: del conte a. Hum Genet. 2025 Mar;144(2-3):309-326. doi: 10.1007/s00439-025-02733-1. Epub 2025 Feb 28. Hum Genet. 2025. PMID: 40019509 Free PMC article.
Oral LPCN 1148 improves sarcopenia and hepatic encephalopathy in male patients with cirrhosis: A randomized, placebo-controlled phase 2 trial.
Bruno BJ, Weavil JC, Ogle J, Chidambaram N, Carey EJ, Danford CJ, Fricker ZP, Galati JS, Lee WM, Mantry PS, Shetty K, DelConte A, Patel MV, Lai JC, Sanyal AJ. Bruno BJ, et al. Hepatology. 2025 Jun 1;81(6):1764-1775. doi: 10.1097/HEP.0000000000001146. Epub 2025 Jan 31. Hepatology. 2025. PMID: 39513970 Free PMC article. Clinical Trial.
The Change in Paradigm for NSCLC Patients with EML4-ALK Translocation.
Bearz A, De Carlo E, Del Conte A, Spina M, Da Ros V, Bertoli E, Revelant A, Stanzione B, Tirelli U. Bearz A, et al. Among authors: del conte a. Int J Mol Sci. 2022 Jun 30;23(13):7322. doi: 10.3390/ijms23137322. Int J Mol Sci. 2022. PMID: 35806325 Free PMC article. Review.
92 results